Core Viewpoint - Lakeland Industries, Inc. is expanding its services in California by opening a new facility for personal protective equipment (PPE) care and maintenance, which will enhance support for local fire departments and comply with NFPA 1850 standards [2][5]. Group 1: Facility Overview - The new facility, "California PPE, Fresno," spans 9,800 square feet and is equipped with advanced cleaning and repair equipment, including Circul-Air Genius extractors and commercial Juki sewing machines [3]. - The facility will provide decontamination, inspection, and repair services to California Fire Departments, adhering to NFPA 1850 guidelines aimed at reducing health and safety risks [3][5]. Group 2: Training and Events - California PPE will conduct NFPA 1850 classes to train fire department personnel on the selection, care, and maintenance of firefighter PPE and self-contained breathing apparatus (SCBA) [4]. - The first NFPA 1850 class is scheduled for March 3-4, 2026, followed by a grand opening event on March 4, 2026, which will include an open house for fire departments [4]. Group 3: Market Position and Strategy - Lakeland Fire + Safety is recognized as a leading manufacturer of protective clothing and PPE services, with a strong reputation for quality service and customer satisfaction in the firefighting services market [5]. - The expansion into California, which has the largest number of firefighters in the U.S., is a strategic move to enhance coverage and support for fire departments across the state [5].

Core Insights - Playboy, Inc. has appointed David Miller as President, Media & Brand to drive the next phase of the Company's growth strategy [1][4] - Miller's extensive experience includes leadership roles at The Walt Disney Company and AOL, where he significantly expanded digital media operations [2][3] - The appointment is part of Playboy's broader strategy to enhance its media and licensing operations, aiming for sustainable and profitable growth [5][6] Company Overview - Playboy is a global pleasure and leisure company known for its iconic brand, pursuing an asset-light model across various sectors including licensing and digital content [7] - The Company aims to leverage its intellectual property to enhance consumer experiences and drive revenue growth [7] Leadership and Strategy - David Miller's role will focus on scaling Playboy's media business and licensing operations, utilizing his expertise to accelerate revenue and brand reach [4] - CEO Ben Kohn emphasized that Miller's appointment allows for a more aggressive execution of growth strategies, including new membership clubs and original programming [5][6] - The leadership team believes that the Company is building a diversified, high-margin business with significant upside potential [6]

Core Insights - Disc Medicine, Inc. reported financial results for Q4 and full year 2025, highlighting progress in its clinical programs and a strong cash position [1][5][6] Financial Performance - Cash, cash equivalents, and marketable securities totaled approximately $791 million as of December 31, 2025, up from $490 million in 2024, providing a runway into 2029 [6][11] - Research and Development (R&D) expenses increased to $170.6 million in 2025 from $96.7 million in 2024, driven by advancements in clinical studies and increased headcount [11][13] - Selling, General and Administrative (SG&A) expenses rose to $65.4 million in 2025 from $33.0 million in 2024, primarily due to increased headcount and infrastructure development [11][13] - The net loss for 2025 was $212.2 million, compared to a net loss of $109.4 million in 2024, attributed to higher operating costs [11][13] Clinical Developments - The Phase 3 APOLLO study for bitopertin is expected to complete enrollment in March 2026, with topline data anticipated in Q4 2026 [6][7] - Initial data from the Phase 2 study of DISC-0974 in patients with anemia of myelofibrosis (MF) showed meaningful overall anemia responses across all patient subgroups [6][7] - The company is progressing with the Phase 2 study of DISC-3405 in polycythemia vera and has initiated a Phase 1b study in sickle cell disease, with data expected in the second half of 2026 [6][7] Pipeline Overview - Bitopertin is a GlyT1 inhibitor aimed at treating erythropoietic protoporphyria (EPP) [3] - DISC-0974 is an anti-hemojuvelin antibody focused on hepcidin suppression [4] - DISC-3405 is an anti-TMPRSS6 antibody targeting hepcidin induction [4]

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Satellogic, Inc. (NASDAQ: SATL), a vertically integrated geospatial company delivering high-resolution Earth Observation (EO) at unprecedented scale and economics, will hold a conference call on Thursday, March 19, 2026 at 8:00 a.m. Eastern time to discuss its results for the fourth quarter and fiscal year 2025 ended December 31, 2025, and will be providing updates on recent commercial advancements, partnerships, and other initiatives and milestones. Satellogic’s ...

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- via AINewsWire -- Nightfood Holdings Inc. (NGTF) today announces its placement in an editorial published by AINewsWire ("AINW"), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “AI-Service Robotics Transition Toward Revenue-Driven Deployment Accele ...

Strategic Access to AMD Developer Cloud Expected to Accelerate High-Performance AI Video Generation, and Future Enterprise Automation and Scalable DeploymentFREEHOLD, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced that it has been accepted into the Advanced Micro Devices (“AMD”) AI Developer Program, ...

Accepted Abstract Highlights Metabolic Response Observations Following Chemotherapeutic Drug-Delivery via the TAMP™ Therapy Platform in Patients Diagnosed with Locally Advanced Pancreatic CancerMOUNTAIN VIEW, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life-sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug-delivery device, today announced that a clinical data abstract s ...

HOUSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Founder and Chief Executive Officer, Pete O’Heeron, will present at the BIO Investment & Growth Summit taking place March 2-3, 2026, at the Eden Roc in Miami Beach, FL. FibroB ...

Core Viewpoint - Guardforce AI Co., Limited has extended its partnership to provide smart retail solutions to a major global sportswear brand in Thailand, indicating a strong market presence and growth potential in the retail sector [1][2]. Group 1: Partnership and Deployment - The extended partnership positions Guardforce AI as a key technology partner in the client's national renovation plan, with the first batch of requests for smart retail solutions at five additional locations in 2026 and one more in 2027 [2]. - Previously, the company deployed similar solutions at two locations and installed AI camera systems across 13 additional stores in 2025 after a successful proof of concept [3]. Group 2: Smart Retail Solutions - Guardforce AI's smart retail solution combines AI-driven CCTV surveillance analytics and RFID-based inventory systems, enhancing operational efficiency for high-traffic retailers compared to traditional systems [4]. - The solutions aim to enhance store security, reduce theft, decrease inventory inaccuracies, minimize manual labor, optimize store layouts, correlate foot traffic with sales, and provide performance metrics across multiple locations [7]. Group 3: Future Growth Potential - The company believes that these smart solutions can be further deployed across many of the 5,000 retail stores it currently serves, which could generate substantial revenue and drive exponential growth compared to 2025 [4]. - The Chairwoman and CEO expressed optimism about announcing further developments in the company's smart retail solutions soon [4]. Group 4: Company Overview - Guardforce AI is an AI-driven technology company with a strong operational foundation in cash logistics and retail sectors, delivering next-generation smart solutions and AI applications [5]. - The company is expanding into new areas such as travel planning, showcasing its scalable AI capabilities to drive industry transformation [5].

Core Insights - The company experienced a significant decline in net trading income due to lower client trading activity and a temporary pause in EU client onboarding, resulting in a net trading income of EUR -1.0 million for 2025 compared to EUR 13.5 million in 2024 [1][6] - The company reported a net loss of EUR -16.2 million for 2025, a stark contrast to a net profit of EUR 0.4 million in 2024, indicating a challenging financial year [6][7] - The number of active clients decreased to 29,455, highlighting the need for the company to focus on rebuilding and expanding its client base [6] Financial Performance - Total assets decreased from EUR 74.69 million in 2024 to EUR 62.03 million in 2025, reflecting a decline in various asset categories [4] - Total liabilities increased from EUR 4.45 million in 2024 to EUR 7.95 million in 2025, indicating a rise in financial obligations [4] - Total equity fell from EUR 70.24 million in 2024 to EUR 54.08 million in 2025, primarily due to retained earnings decreasing from EUR 67.40 million to EUR 51.24 million [4] Revenue Breakdown - Net gains from trading of financial assets decreased significantly from EUR 37.44 million in 2024 to EUR 18.49 million in 2025 [5] - Brokerage and commission fee revenue also declined from EUR 1.06 million in 2024 to EUR 0.80 million in 2025, while brokerage and commission fee expenses decreased from EUR 25.45 million to EUR 20.52 million [5] - Other income similar to interest was reported as zero in 2025, down from EUR 0.085 million in 2024 [5] Strategic Focus - The company aims to rebuild its active client base, improve client activation and retention, and maintain disciplined cost management and compliance to support long-term value creation [3][6] - Client acquisition efforts were intensified in the second quarter of 2025 following the resumption of EU client onboarding in March 2025 [2]